In 2023, the mortality rate for bladder malignant neoplasms among men in Japan stood at [data needed]. Between 2024 and 2028, the forecasted mortality rates show a steady increase from 11.1 to 11.9 male deaths per hundred thousand men, showcasing an annual growth rate of approximately 1.8% year-on-year. The compounded annual growth rate (CAGR) over the five-year forecast further indicates a uniform upward trend.
Future trends to watch for include advancements in medical treatments and preventive measures, changes in environmental factors or lifestyle habits, and potential healthcare policy shifts, which could impact these mortality forecasts. Monitoring these trends will be crucial for stakeholders in healthcare planning and resource allocation.
